ImportantUpdates
Dr. Lal PathLabs declared financial results: Q revenue at 730.6 Cr, profit 150.6 Cr.
Dr. Lal Path Labs Ltd.LALPATHLAB · Filed with the exchange
H1 revenue reached 1,400.4 Cr, profit 283.0 Cr.
The board approved an INR 7 interim dividend and a 1:1 bonus share issue, pending shareholder approval.
Operational changes included the liquidation of Suburban Diagnostics.
No comments yet. Be the first.